Stay updated on Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.

Latest updates to the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page
- Check4 days agoChange DetectedFooter now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedMinor update to the study page indicating a revision from v3.3.1 to v3.3.2; no substantive changes to study design, inclusion criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed. This update does not modify any study data, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check40 days agoChange DetectedThe government operating status banner regarding funding lapses was removed from the page.SummaryDifference0.4%

- Check54 days agoChange DetectedNo significant changes to core study information were detected; the differences appear to be limited to formatting and layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedCore content updated to include a government-status notice and a new version tag (v3.2.0); a specific resource entry was removed (Nevoid basal cell carcinoma syndrome).SummaryDifference4%

Stay in the know with updates to Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.